Publications | Together We Advance | Qral Group LLC

Publications

[ Research ] A Journey with LGMD: From Protein Abnormalities to Patient Impact

[ White Paper ] Adaptive Transformation: US Healthcare Burden

[ White Paper ] Adaptive Transformation: Pharma Sales Bend or Break

[ White Paper ] Adaptive Transformation: Telemedicine Comes of Age

[ White Paper ] Adaptive Transformation: Voices from the Front Line

[ White Paper ] COVID-19 Patient Journey - Progression, Diagnosis, and Treatments in Development

Payers Leverage Off Label Bevacizumab to Control Opht Costs

Keeping it Fair in Rare -- What every Pharma can Learn from Ultra-Orphan Sales Incentive Plan Design

$200,000 the new max? Payers start to redefine “Proven and Medically Necessary”

Claims Data Analytics. Now Available for Pipeline Brands.

Alignments from scratch in hours, not weeks, not months. Data included.

You Won President's Club. Again. Great! Now What?

Ultra Orphan IC Design

Observations from Tableau Conference 2016

Observations from 2017 JPM

Qral Group Named “Best Vendor Partner” By TGaS Advisors

CONTACT

New York 646.926.0208

Chicago 847.868.0208

San Francisco 415.347.9565

Boston 617.229.6063

Delhi +91-1244006616

© 2023 Qral Group LLC